As a young man, I was privileged to be an eyewitness to the rise of the Christian spiritual formation movement. It began, in its modern form, in 1978, when Richard Foster wrote what has become the ...

The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi will explore additional indications for gusacitinib in a Phase I study.

Having secured one of last year’s largest funding rounds, AI-focused Formation Bio is now eyeing up 545 million euros ($626 million) in potential paydays from a licensing deal with Sanofi. The French ...

Spiritual formation shouldn’t be an attempt to control ministry outcomes—it’s about cultivating space for God to work. I recently read about a spiritual formation program that went terribly wrong. A ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months ...

EXCLUSIVE: Atlanta-based talent agency People Store has rebranded as Formation Talent Agency, brining in veteran agent Lauren Williams to serve as Senior Vice President of Talent amidst this evolution ...

It took just one game of the 2024 season to land NFL officiating back in the discourse. On the second play of Thursday night's game between the Kansas City Chiefs and Baltimore Ravens, referee Shawn ...

The Ravens scored the first touchdown of the 2024 NFL season when Derrick Henry plowed into the end zone on a five-yard run. It came despite some early struggles with illegal formation penalties.

June 26 (Reuters) - AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage funding round, with a significant participation from French drugmaker Sanofi ...

Formation Bio, a startup focused on applying AI to drug development with backing from OpenAI CEO Sam Altman, has raised over a quarter-billion dollars to support its ambitious product roadmap.

May 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development ...